局解手术学杂志2024,Vol.33Issue(4) :355-358.DOI:10.11659/jjssx.04E023069

临界可切除性胰腺癌的研究现状与展望

Research status and prospect of borderline resectable pancreatic cancer

黄诗佳 梁荣 汪思宇 胡议予 肖枭 汪伟民 苗春木 王运兵 丁雄
局解手术学杂志2024,Vol.33Issue(4) :355-358.DOI:10.11659/jjssx.04E023069

临界可切除性胰腺癌的研究现状与展望

Research status and prospect of borderline resectable pancreatic cancer

黄诗佳 1梁荣 1汪思宇 2胡议予 2肖枭 1汪伟民 1苗春木 1王运兵 1丁雄1
扫码查看

作者信息

  • 1. 重庆医科大学附属第二医院肝胆外科,重庆 400010
  • 2. 重庆医科大学第二临床学院,重庆 400000
  • 折叠

摘要

胰腺癌发病率高,恶性程度高,预后差.临界可切除性胰腺癌(BRPC)是胰腺癌的一个重要类型,也是最近的研究热点.提高BRPC的疗效,有助于从总体上改善胰腺癌人群的预后.BRPC的概念近些年来有所更新,但目前仍缺乏一致的治疗方案.本文就BRPC的研究现状进行分析,包括对BRPC概念的演变和治疗现状的综述,并对未来研究的方向进行展望,以期为临床BRPC治疗方式的选择提供参考.

Abstract

Pancreatic cancer has high incidence,high malignancy and poor prognosis.Borderline resectable pancreatic cancer(BRPC)is an important type of pancreatic cancer,which is also a recent research hotspot.Improving the efficacy of BRPC is helpful to improve the prognosis of pancreatic cancer population as a whole.The concept of BRPC has been updated in recent years,but there is currently a lack of consistent treatment plans for BRPC.This article analyzes the current research status of BRPC,including the review of the evolution of the concept and treatment status of BRPC,and prospects for future research directions,aiming to provide a reference basis for the selection of clinical treatment methods of BRPC.

关键词

临界可切除性胰腺癌/手术切除/新辅助化疗/放射治疗

Key words

borderline resectable pancreatic cancer/surgical resection/neoadjuvant chemotherapy/radiation therapy

引用本文复制引用

基金项目

重庆市自然科学基金面上项目(cstc2021jcyjmsxmX0294)

重庆市自然科学基金博士后项目(cstc2020jcyjbshX0033)

重庆市科卫联合项目(2021MSXM139)

出版年

2024
局解手术学杂志
重庆市解剖学会,第三军医大学

局解手术学杂志

CSTPCD
影响因子:1.063
ISSN:1672-5042
参考文献量26
段落导航相关论文